Prosecution Insights
Last updated: April 18, 2026
Application No. 16/655,094

DRIP CHAMBER WITH NEEDLE VALVE

Non-Final OA §102§103§112
Filed
Oct 16, 2019
Examiner
PATEL, SHEFALI DILIP
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Carefusion 303 Inc.
OA Round
9 (Non-Final)
58%
Grant Probability
Moderate
9-10
OA Rounds
4y 0m
To Grant
86%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allow Rate
427 granted / 734 resolved
-11.8% vs TC avg
Strong +28% interview lift
Without
With
+27.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
54 currently pending
Career history
788
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
39.4%
-0.6% vs TC avg
§102
25.2%
-14.8% vs TC avg
§112
26.7%
-13.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 734 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on December 8, 2025, has been entered. Acknowledgments In the reply, filed on December 8, 2025, Applicant amended claims 5 and 18. Applicant cancelled claim 8. In the final rejection of September 8, 2025, Examiner objected to claim 18. Applicant amended claim 18. Objection is withdrawn. Examiner rejected claims 5, 7-8, 10, 13-16, and 18-20 under 35 U.S.C. 112(a). Applicant amended claims 5 and 18. Rejection is withdrawn. Examiner rejected claims 18-20 under 35 U.S.C. 112(b). Applicant amended claim 18. Rejection is withdrawn. Currently, claims 5, 7, 10, 13-16, and 18-20 are under examination. Claim Objections Claims 5 and 18 are objected to because of the following informalities: In regards to claim 5, line 5, “the environment” should be changed to “an environment”. In regards to claim 18, line 5, “the environment” should be changed to “an environment”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 5, 7, 10, 13-16, and 18-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In regards to claim 5, lines 3-5 recite: an air vent between “the chamber volume the environment”. It is unclear what is meant by the term “the chamber volume the environment” as there may be terms missing between “the chamber volume” and “the environment”. Claims 7, 10, and 13-16 are rejected by virtue of being dependent upon claim 5. In regards to claim 18, lines 4-5 recite: the chamber body comprising “an air vent the environment”. It is unclear what is meant by the term “an air vent the environment” as there may be terms missing between “an air vent” and “the environment”. Claims 19-20 are rejected by virtue of being dependent upon claim 18. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 18-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Darling (US 5,730,730). In regards to claim 18, Darling teaches a method to control fluid flow through a drip chamber (10), the method comprising: providing a chamber body (30) defining a chamber volume (60), a spike (46), and an inlet tube (138), the chamber body comprising an air vent (90) the environment, and the chamber volume configured to receive the fluid flow from the inlet tube (Figure 3) providing a valve body (104) coupled to the chamber body via a chamber body coupling of the valve body, wherein the valve body is disposed as a chamber body outlet such that a fluid from the chamber volume can enter a valve inlet (100) of the valve body (Figure 3) wherein the valve body comprises a frustoconical movable needle valve surface (108) movable between a first position radially closer to a frustoconical fixed needle valve surface (flow path between channels 100 and 102) and decreasing a cross-sectional area of a flow path defined by the frustoconical fixed needle valve surface and the frustoconical movable needle valve surface between the valve inlet and a valve outlet (102) both extending through the frustoconical fixed needle valve surface (Figure 3), and a second position radially spaced apart from the fixed needle valve surface and increasing the cross-sectional area of the flow path between the valve inlet and the valve outlet (column 7, lines 5-10: tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate), wherein the frustoconical movable needle valve surface is nested within the frustoconical fixed needle valve surface and the fluid flow passes through the valve inlet and the valve outlet both extending through the frustoconical fixed needle valve surface (Figure 3), wherein the frustoconical movable needle valve surface is movable between the first position and the second position to control the fluid flow out of the valve body (Figure 3)(column 7, lines 5-10: tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate) In regards to claim 19, Darling teaches rotating a knob (110) to move the movable needle valve surface relative to the fixed needle valve surface (column 7, lines 4-13: An external control knob 110 connected to a proximal end of shaft 106 enables a user to rotate the shaft so that tapered section 108 is drawn to the right… A fluid flow indicating scale 112 may be provided beneath knob 110 to indicate, according to the rotational position of the knob). In regards to claim 20, Darling teaches axially moving a knob to move the movable needle valve surface relative to the fixed needle valve surface (column 7, lines 4-6: An external control knob 110 connected to a proximal end of shaft 106 enables a user to rotate the shaft so that tapered section 108 is drawn to the right). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 5, 7, 10, and 13-16 are rejected under 35 U.S.C. 103 as being unpatentable over Darling. In regards to claim 5, Darling teaches a drip chamber (Figures 1-4) comprising: a chamber body (30) defining a chamber volume (60), the chamber body comprising a spike (46), an inlet tube (138), and an air vent (90) between the chamber volume the environment a valve body (104) coupled to the chamber body, the valve body comprising: a chamber body coupling to receive and couple to the chamber body, wherein the valve body is disposed as a chamber body outlet such that a fluid from the chamber volume can enter the valve body (Figure 3) a valve inlet (100) a valve outlet (102) a needle valve assembly comprising: a fixed needle valve surface (flow path between channels 100 and 102), wherein the fixed needle valve surface is frustoconical, the valve inlet extends through the frustoconical fixed needle valve surface, and the valve outlet extends through the frustoconical fixed needle valve surface (Figure 3) a movable needle valve surface (108), wherein the movable needle valve surface is frustoconical, nested within the frustoconical fixed needle valve surface (Figure 3), and the movable needle valve surface is axially movable between a first position radially closer to the fixed needle valve surface and decreasing a cross-sectional area of a flow path defined by the frustoconical fixed needle valve surface and the frustoconical movable needle valve surface between the valve inlet and the valve outlet (Figure 3) and a second position radially spaced apart from the fixed needle valve surface and increasing the cross-sectional area of the flow path between the valve inlet and the valve outlet to control a flow rate between the valve inlet and the valve outlet (column 7, lines 5-10: tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate) Darling does not teach the inlet tube extending through the spike, as Darling only teaches the inlet tube extending from the spike (Figure 3). But before the effective filing date of the claimed invention, it would have been an obvious matter of design choice to a person having ordinary skill in the art to modify the inlet tube extending from the spike, of the chamber of Darling, to also extend through the spike, as Applicant has not disclosed that such a configuration of the inlet tube with respect to the spike provides an advantage, is used for a particular purpose, or solves a stated problem. One of ordinary skill in the art, furthermore, would have expected Applicant’s invention to perform equally well with the inlet tube only extending from the spike, as taught by Darling, as either configuration of the inlet tube with respect to the spike will provide for the same end result of communicating liquid from the spike to the chamber body. In regards to claim 7, in the modified chamber of Darling, Darling teaches wherein the spike defines a spike flow path in fluid communication with the chamber volume (Figure 3). In regards to claim 10, in the modified chamber of Darling, Darling teaches wherein the valve inlet is in fluid communication with the chamber volume (Figure 3). In regards to claim 13, in the modified chamber of Darling, Darling teaches a movable knob (110), wherein actuating the knob actuates the movable needle valve surface to control the flow rate between the valve inlet and the valve outlet (column 7, lines 4-10: An external control knob 110 connected to a proximal end of shaft 106 enables a user to rotate the shaft so that tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate). In regards to claim 14, in the modified chamber of Darling, Darling teaches wherein the movable knob is in threaded engagement with the valve body (Figure 3) and rotating the knob actuates the movable needle valve surface to control the flow rate between the valve inlet and the valve outlet (column 7, lines 4-14: An external control knob 110 connected to a proximal end of shaft 106 enables a user to rotate the shaft so that tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate. A fluid flow indicating scale 112 may be provided beneath knob 110 to indicate, according to the rotational position of the knob, the precise fluid flow rate through regulating means 66). In regards to claim 15, in the modified chamber of Darling, Darling teaches wherein the movable knob is axially movable relative to the valve body and axially moving the knob actuates the movable needle valve surface to control the flow rate between the valve inlet and the valve outlet (column 7, lines 4-10: An external control knob 110 connected to a proximal end of shaft 106 enables a user to rotate the shaft so that tapered section 108 is drawn to the right. This action opens, in varying degrees, the flow path between channels 100 and 102 so as to provide a variable cross section conduit enabling the regulation of fluid flow from upper chamber 60 into lower chamber 62, to the desired or required flow rate). In regards to claim 16, in the modified chamber of Darling, Darling teaches wherein the movable knob defines the movable needle valve surface (Figure 3). Response to Arguments Applicant’s arguments with respect to claims 5, 7, 10, 13-16, and 18-20 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHEFALI D PATEL whose telephone number is (571)270-3645. The examiner can normally be reached Monday-Friday 8:30am-4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin C Sirmons can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHEFALI D PATEL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Oct 16, 2019
Application Filed
Jan 27, 2023
Non-Final Rejection — §102, §103, §112
May 02, 2023
Response Filed
Jul 01, 2023
Final Rejection — §102, §103, §112
Aug 03, 2023
Response after Non-Final Action
Aug 15, 2023
Response after Non-Final Action
Sep 29, 2023
Request for Continued Examination
Oct 03, 2023
Response after Non-Final Action
Oct 20, 2023
Non-Final Rejection — §102, §103, §112
Jan 11, 2024
Response Filed
Apr 06, 2024
Final Rejection — §102, §103, §112
Jul 08, 2024
Response after Non-Final Action
Jul 29, 2024
Response after Non-Final Action
Aug 12, 2024
Request for Continued Examination
Aug 13, 2024
Response after Non-Final Action
Aug 16, 2024
Non-Final Rejection — §102, §103, §112
Oct 29, 2024
Response Filed
Dec 30, 2024
Final Rejection — §102, §103, §112
Feb 27, 2025
Response after Non-Final Action
Apr 07, 2025
Request for Continued Examination
Apr 08, 2025
Response after Non-Final Action
Apr 16, 2025
Non-Final Rejection — §102, §103, §112
Jul 17, 2025
Response Filed
Sep 05, 2025
Final Rejection — §102, §103, §112
Nov 02, 2025
Response after Non-Final Action
Dec 08, 2025
Request for Continued Examination
Dec 14, 2025
Response after Non-Final Action
Dec 23, 2025
Non-Final Rejection — §102, §103, §112
Mar 26, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599708
PERITONEAL DIALYSIS CASSETTE
2y 5m to grant Granted Apr 14, 2026
Patent 12589219
STEERABLE SHEATH WITH VARIABLE CURVE SPAN
2y 5m to grant Granted Mar 31, 2026
Patent 12582775
PULSATILE OR RESONATING FLUSH SYRINGE
2y 5m to grant Granted Mar 24, 2026
Patent 12564678
SYSTEMS AND METHODS FOR OPTIMIZING MEDICAMENT DOSING
2y 5m to grant Granted Mar 03, 2026
Patent 12551605
FLUID LINE AUTOCONNECT APPARATUS AND METHODS FOR MEDICAL TREATMENT SYSTEM
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

9-10
Expected OA Rounds
58%
Grant Probability
86%
With Interview (+27.7%)
4y 0m
Median Time to Grant
High
PTA Risk
Based on 734 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month